Home > Back to Publisher > Report Information

Determining European KOL Compensation Fair-Market Value Benchmarks

Cutting Edge Information
January 1, 2011
181 Pages - SKU: CIGQ6126545

Abstract Table of Contents Related Reports

Countries covered: Europe

The pressure on drug and device companies to disclose their payments to key opinion leaders (KOLs) has emerged in Europe. Life sciences companies that had developed policies to manage disclosure requirements in the United States are now applying similar approaches to Europe and other parts of the world. To remain compliant with government regulations, industry codes and various agencies’ guidelines, drug and device companies must understand the fair-market value (FMV) for KOLs’ consulting and advisory services.

Cutting Edge Information is a leader in FMV benchmarking. Stay ahead of the competition with the only FMV benchmarking report focused on Europe. For the first time, Cutting Edge Information has developed a report that provides FMV benchmarks specific to European KOLs. The benchmarks included in this report allow life sciences companies to set FMV fee schedules in Europe. This study provides compensation data for European KOLs across 29 therapeutic areas.

Determine FMV compensation for European KOLs: Use the thousands of compensation benchmarks contained in this report to determine payments for opinion leaders across Europe. Use benchmarking data to find appropriate spending levels for companies of your size and for specific consulting and advisory activities.
Ensure compliant compensation levels: Global policies increasingly require FMV payments to remain compliant across regions. Avoid overpaying or underpaying your thought leaders for specific activities.Remain competitive and attract new thought leader relationships, while staying compliant with your compensation levels.
Compare Europe -- US FMV fees: Although fair-market value trends and practices originated in the US, they differ for European thought leaders. Learn the differences between FMV in Europe and the US to set an appropriate fee schedule for your European KOLs.

Executive Summary: Profiled Companies; Study Methodology; Study Definitions; European Fair-Market Value Compensation: Key Trends
European Fair-Market Value: Generalized Data and Europe-US Comparison: Task Duration; Aggregated Fair-Market Value Data for Europe and the United States
European Fair-Market Value: Payments by Company Size and Type: Small Company Payments; Large Company Payments; Payments by Other Company Types; Travel Expenses and Annual Compensation Caps
Appendix A: Fair-Market Value Benchmarks for Thought Leader Providers by Company Size
Appendix B: Fair-Market Value Benchmarks for Thought Leader Providers by Provider Type
Appendix C: Fair-Market Value Benchmarks for Healthcare Professionals by Company Size
Appendix D: Fair-Market Value Benchmarks for Healthcare Professionals by Provider Category
CHARTS AND GRAPHICS
Executive Summary: Figure E.1: The Shrinking Thought Leader Pool (US Data); Figure E.2: Decrease in Average Hourly Rates (US Data); Figure E.3: Percentage of Companies with and without Annual Compensation Limits; Figure E.4: Annual Compensation Caps - Europe
European Fair-Market Value: Generalized Data and Europe-US Comparison
Task Duration: Figure 1.1: Average Duration of Thought Leader Tasks (US vs. Europe)
Aggregated Fair-Market Value Data for Europe and the United States: Figure 1.2: Flat Fee Ranges Across All Therapeutic Areas, Thought Leader Categories and Consulting Activities by Company Type; Figure 1.3: US: Flat Fee Ranges Across All Therapeutic Areas, Thought Leader Categories and Consulting Activities by Company Type; Figure 1.4: Hourly Rate Ranges Across All Therapeutic Areas, Thought Leader Categories and Consulting Activities by Company Type; Figure 1.5: US: Hourly Rate Ranges Across All Therapeutic Areas, Thought Leader Categories and Consulting Activities by Company Type; Figure 1.6: Honoraria Across All Therapeutic Areas, Thought Leader Categories and Consulting Activities by Company Type; Figure 1.7: Average Flat Fees for Speakers Across All Therapeutic Areas and Thought Leader Categories by Company Size; Figure 1.8: US: Average Flat Fees for Speakers Across All Therapeutic Areas and Thought Leader Categories by Company Size; Figure 1.9: Average Flat Fees for Advisory Panels Across All Therapeutic Areas and Thought Leader Categories by Company Size; Figure 1.10: US: Average Flat Fees for Advisory Panels Across All Therapeutic Areas and Thought Leader Categories by Company Size; Figure 1.11: Average Flat Fees for Authorships Across All Therapeutic Areas and Thought Leader Categories by Company Size; Figure 1.12: US: Average Flat Fees for Authorships Across All Therapeutic Areas and Thought Leader Categories by Company Size; Figure 1.13: Average Flat Fees for Consulting Across All Therapeutic Areas and Thought Leader Categories by Company Size; Figure 1.14: Average Hourly Rates for Speakers Across All Therapeutic Areas and Thought Leader Categories by Company Size; Figure 1.15: Average Hourly Rates for Consulting Across All Therapeutic Areas and Thought Leader Categories by Company Size; Figure 1.16: Average Hourly Rates for Advisory Boards Across All Therapeutic Areas and Thought Leader Categories by Company Size; Figure 1.17: Average Hourly Rates for Authorships Across All Therapeutic Areas and Thought Leader Categories by Company Size; Figure 1.18: Average Honoraria for Consulting Across All Therapeutic Areas and Thought Leader Categories by Company Size; Figure 1.19: Average Honoraria for Advisory Boards Across All Therapeutic Areas and Thought Leader Categories by Company Size; Figure 1.20: Average Flat Fee Ranges Across All Therapeutic Areas and Company Sizes by Thought Leader Provider Type; Figure 1.21: Average Hourly Rate Ranges Across All Therapeutic Areas and Company Sizes by Thought Leader
Provider Type: Figure 1.22: US: Average Hourly Rate Ranges Across All Therapeutic Areas and Company Sizes by Thought Leader Provider Type; Figure 1.23: Average Honoraria Across All Therapeutic Areas and Company Sizes by Thought Leader Provider Type; Figure 1.24: Average Hourly Rate Ranges Across All Therapeutic Areas and Company Sizes for Healthcare Professionals; Figure 1.25: Average Flat Fee Ranges Across All Therapeutic Areas and Company Sizes for Healthcare Professionals; Figure 1.26: Average Honoraria Across All Therapeutic Areas and Company Sizes for Healthcare Professionals
European Fair-Market Value: Payments by Company Size and Type
Small Company Payments: Figure 2.1: Small Companies’ Average Hourly Rates for Consulting by Thought Leader Provider Type; Figure 2.2: Small Companies’ Average Hourly Rates for Delivering a Scientific Speech by Thought Leader Provider Type; Figure 2.3: Small Companies’ Average Hourly Rates for Advisory Panels by Thought Leader Provider Type; Figure 2.4: Small Companies’ Average Hourly Rates for Authorships by Thought Leader Provider Type; Figure 2.5: Small Companies’ Average Hourly Rates for Consulting for Healthcare Professionals; Figure 2.6: Small Companies’ Average Hourly Rates for Advisory Panels for Healthcare Professionals; Figure 2.7: Small Companies’ Average Flat Fees for Commercial Consulting by Thought Leader Provider Type; Figure 2.8: Small Companies’ Average Flat Fees for Speaking by Thought Leader Provider Type; Figure 2.9: Small Companies’ Average Flat Fees for Leading Advisory Panels by Thought Leader Provider Type; Figure 2.10: Small Companies’ Average Flat Fees for Consulting for Healthcare Professionals; Figure 2.11: Small Companies’ Average Flat Fees for Delivering a Scientific Speech for Healthcare Professionals; Figure 2.12: Small Companies’ Average Flat Fees for Leading an Advisory Panel for Healthcare Professionals; Figure 2.13: Small Companies’ Average Flat Fees for Authoring a Manuscript for Healthcare Professionals; Figure 2.14: Small Companies’ Average Honoraria for Consulting by Thought Leader Provider Type; Figure 2.15: Small Companies’ Average Honoraria for Delivering a Scientific Speech by Thought Leader Provider Type; Figure 2.16: Small Companies’ Average Honoraria for Advisory Panels by Thought Leader Provider Type; Figure 2.17: Small Companies’ Average Honoraria for Clinical Consulting for Healthcare Professionals; Figure 2.18: Small Companies’ Average Honoraria for Advisory Boards for Healthcare Professionals
Large Company Payments: Figure 2.19: Large Companies’ Average Hourly Rates for Consulting by Thought Leader Provider Type; Figure 2.20: Large Companies’ Average Hourly Rates for Speaking by Thought Leader Provider Type; Figure 2.21: Large Companies’ Average Hourly Rates for Advisory Panels by Thought Leader Provider Type; Figure 2.22: Large Companies’ Average Hourly Rates for Authorships by Thought Leader Provider Type; Figure 2.23: Large Companies’ Average Hourly Rates for Consulting for Healthcare Professionals; Figure 2.24: Large Companies’ Average Hourly Rates for Speaking for Healthcare Professionals; Figure 2.25: Large Companies’ Average Hourly Rates for Advisory Boards for Healthcare Professionals; Figure 2.26: Large Companies’ Average Hourly Rates for Authorships for Healthcare Professionals; Figure 2.27: Large Companies’ Average Flat Fees for Consulting by Thought Leader Provider Type; Figure 2.28: Large Companies’ Average Flat Fees for Speaking by Thought Leader Provider Type; Figure 2.29: Large Companies’ Average Flat Fees for Advisory Panels by Thought Leader Provider Type; Figure 2.30: Large Companies’ Average Flat Fees for Authorships by Thought Leader Provider Type; Figure 2.31: Large Companies’ Average Flat Fees for Consulting for Healthcare Professionals; Figure 2.32: Large Companies’ Average Flat Fees for Speaking for Healthcare Professionals; Figure 2.33: Large Companies’ Average Flat Fees for Advisory Boards for Healthcare Professionals; Figure 2.34: Large Companies’ Average Flat Fees for Authorships for Healthcare Professionals
Payments by Other Company Types: Figure 2.35: Other Companies’ Average Hourly Rates for Consulting by Thought Leader Provider Type; Figure 2.36: Other Companies’ Average Hourly Rates for Delivering a Promotional Speech by Thought
Leader Provider Type: Figure 2.37: Other Companies’ Average Hourly Rates for Advisory Boards by Thought Leader Provider Type; Figure 2.38: Other Companies’ Average Hourly Rates for Authorships by Thought Leader Provider Type; Figure 2.39: Other Companies’ Average Hourly Rates for Delivering a Scientific Speech for
Healthcare Professionals: Figure 2.40: Other Companies’ Average Hourly Rates for Authorships by Healthcare Professionals; Figure 2.41: Other Companies’ Average Flat Rates for Commercial Consulting by Thought Leader Provider Type; Figure 2.42: Other Companies’ Average Flat Rates for Speaking by Thought Leader Provider Type; Figure 2.43: Other Companies’ Average Flat Rates for Advisory Boards by Thought Leader Provider Type; Figure 2.44: Other Companies’ Average Flat Rates for Authorships by Thought Leader Provider Type; Figure 2.45: Other Companies’ Average Flat Rates for Clinical Consulting by Healthcare Professionals; Figure 2.46: Other Companies’ Average Honoraria for Consulting by Thought Leader Provider Type; Figure 2.47: Other Companies’ Average Honoraria for Advisory Boards by Thought Leader Provider Type; Figure 2.48: Other Companies’ Average Honoraria for Consulting by Healthcare Professionals; Figure 2.49: Other Companies’ Average Honoraria for Advisory Boards by Healthcare Professionals
Travel Expenses and Annual Compensation Caps: Figure 2.50: Percentage of Companies That Compensate for Travel Time Beyond Actual Travel Expenses; Figure 2.51: Percentage of Companies That Compensate for Travel Time Beyond Actual Travel Expenses by Company Size; Figure 2.52: Percentage of Companies That Include Travel and Preparation Costs in General Compensation; Figure 2.53: Percentage of Companies That Include Travel and Preparation Costs in General Compensation by Company Size; Figure 2.54: Percentage of Companies That Implement Annual Compensation Caps for Individual Thought Leaders
Appendix A: Fair-Market Value Benchmarks for Thought Leader Providers by Company Size: Table A.1: All Company Sizes: Fair-Market Value Benchmarks by Activity; Table A.1 (Continued): All Company Sizes: Fair-Market Value Benchmarks by Activity; Table A.1 (Continued): All Company Sizes: Fair-Market Value Benchmarks by Activity; Table A.1 (Continued): All Company Sizes: Fair-Market Value Benchmarks by Activity; Table A.2: Small Companies: Fair-Market Value Benchmarks by Activity; Table A.2: Small Companies (Continued): Fair-Market Value Benchmarks by Activity; Table A.2: Small Companies (Continued): Fair-Market Value Benchmarks by Activity; Table A.2: Small Companies (Continued): Fair-Market Value Benchmarks by Activity; Table A.3: Large Companies: Fair-Market Value Benchmarks by Activity; Table A.3 (Continued): Large Companies: Fair-Market Value Benchmarks by Activity; Table A.3 (Continued): Large Companies: Fair-Market Value Benchmarks by Activity; Table A.3 (Continued): Large Companies: Fair-Market Value Benchmarks by Activity; Table A.4: Other Companies: Fair-Market Value Benchmarks by Activity; Table A.4 (Continued): Other Companies: Fair-Market Value Benchmarks by Activity; Table A.4 (Continued): Other Companies: Fair-Market Value Benchmarks by Activity; Table A.4 (Continued): Other Companies: Fair-Market Value Benchmarks by Activity
Appendix B: Fair-Market Value Benchmarks for Thought Leader Providers by Provider Type: Table B.1: All Provider Categories: Fair-Market Value Benchmarks by Activity; Table B.1 (Continued): All Provider Categories: Fair-Market Value Benchmarks by Activity; Table B.1 (Continued): All Provider Categories: Fair-Market Value Benchmarks by Activity; Table B.1 (Continued): All Provider Categories: Fair-Market Value Benchmarks by Activity; Table B.2: Expert-in-Field: Fair-Market Value Benchmarks by Activity; Table B.2: Expert-in-Field (Continued): Fair-Market Value Benchmarks by Activity; Table B.2: Expert-in-Field (Continued): Fair-Market Value Benchmarks by Activity; Table B.2: Expert-in-Field (Continued): Fair-Market Value Benchmarks by Activity; Table B.3: Specialist: Fair-Market Value Benchmarks by Activity; Table B.3 (Continued): Specialist: Fair-Market Value Benchmarks by Activity; Table B.3: Specialist: Fair-Market Value Benchmarks by Activity; Table B.3: Specialist: Fair-Market Value Benchmarks by Activity; Table B.4: Primary Care Physician: Fair-Market Value Benchmarks by Activity; Table B.4 (Continued): Primary Care Physician: Fair-Market Value Benchmarks by Activity; Table B.4 (Continued): Primary Care Physician: Fair-Market Value Benchmarks by Activity; Table B.4 (Continued): Primary Care Physician: Fair-Market Value Benchmarks by Activity
Appendix C: Fair-Market Value Benchmarks for Healthcare Professionals by Company Size: Table C.1: All Company Sizes: Fair-Market Value Benchmarks by Activity; Table C.1: All Company Sizes: Fair-Market Value Benchmarks by Activity; Table C.1 (Continued): All Company Sizes: Fair-Market Value Benchmarks by Activity; Table C.1 (Continued): All Company Sizes: Fair-Market Value Benchmarks by Activity; Table C.1 (Continued): All Company Sizes: Fair-Market Value Benchmarks by Activity; Table C.1 (Continued): All Company Sizes: Fair-Market Value Benchmarks by Activity; Table C.1 (Continued): All Company Sizes: Fair-Market Value Benchmarks by Activity; Table C.1 (Continued): All Company Sizes: Fair-Market Value Benchmarks by Activity; Table C.2: Small Companies: Fair-Market Value Benchmarks by Activity; Table C.2: Small Companies: Fair-Market Value Benchmarks by Activity; Table C.2: Small Companies (Continued): Fair-Market Value Benchmarks by Activity; Table C.2: Small Companies (Continued): Fair-Market Value Benchmarks by Activity; Table C.2: Small Companies (Continued): Fair-Market Value Benchmarks by Activity; Table C.2: Small Companies (Continued): Fair-Market Value Benchmarks by Activity; Table C.2: Small Companies (Continued): Fair-Market Value Benchmarks by Activity; Table C.2: Small Companies (Continued): Fair-Market Value Benchmarks by Activity; Table C.3: Large Companies: Fair-Market Value Benchmarks by Activity; Table C.3: Large Companies: Fair-Market Value Benchmarks by Activity; Table C.3 (Continued): Large Companies: Fair-Market Value Benchmarks by Activity; Table C.3 (Continued): Large Companies: Fair-Market Value Benchmarks by Activity; Table C.3 (Continued): Large Companies: Fair-Market Value Benchmarks by Activity; Table C.3 (Continued): Large Companies: Fair-Market Value Benchmarks by Activity; Table C.3 (Continued): Large Companies: Fair-Market Value Benchmarks by Activity; Table C.3 (Continued): Large Companies: Fair-Market Value Benchmarks by Activity; Table C.4: Other Companies: Fair-Market Value Benchmarks by Activity; Table C.4: Other Companies: Fair-Market Value Benchmarks by Activity; Table C.4 (Continued): Other Companies: Fair-Market Value Benchmarks by Activity; Table C.4 (Continued): Other Companies: Fair-Market Value Benchmarks by Activity; Table C.4 (Continued): Other Companies: Fair-Market Value Benchmarks by Activity; Table C.4 (Continued): Other Companies: Fair-Market Value Benchmarks by Activity
Appendix D: Fair-Market Value Benchmarks for Healthcare Professionals by Provider Category: Table D.1: All Provider Categories: Fair-Market Value Benchmarks by Activity; Table D.1 (Continued): All Provider Categories: Fair-Market Value Benchmarks by Activity; Table D.1 (Continued): All Provider Categories: Fair-Market Value Benchmarks by Activity; Table D.1 (Continued): All Provider Categories: Fair-Market Value Benchmarks by Activity; Table D.2: Family/General Practitioner: Fair-Market Value Benchmarks by Activity; Table D.2: Family/General Practitioner (Continued): Fair-Market Value Benchmarks by Activity; Table D.2: Family/General Practitioner (Continued): Fair-Market Value Benchmarks by Activity; Table D.2: Family/General Practitioner (Continued): Fair-Market Value Benchmarks by Activity; Table D.3: Internist (Internal Medicine): Fair-Market Value Benchmarks by Activity; Table D.3 (Continued): Internist (Internal Medicine): Fair-Market Value Benchmarks by Activity; Table D.3: Internist (Internal Medicine): Fair-Market Value Benchmarks by Activity; Table D.3: Internist (Internal Medicine): Fair-Market Value Benchmarks by Activity; Table D.4: Nurse Practitioner: Fair-Market Value Benchmarks by Activity; Table D.4 (Continued): Nurse Practitioner: Fair-Market Value Benchmarks by Activity; Table D.4 (Continued): Nurse Practitioner: Fair-Market Value Benchmarks by Activity

More Europe Pharmaceuticals Reports

Insulin - Top 5 European Markets by Global Research & Data Services
This market research report package offers an in-depth perspective on the actual market situation, trends and future outlook for insulin in top 5 European markets. ...

Insulin - Western Europe by Global Research & Data Services
This market research report package offers an in-depth perspective on the actual market situation, trends and future outlook for insulin in Western European markets. The ...

Insulin - Eastern Europe by Global Research & Data Services
This market research report package offers an in-depth perspective on the actual market situation, trends and future outlook for insulin in Eastern European markets. The ...

Insulin - Europe by Global Research & Data Services
This market research report package offers an in-depth perspective on the actual market situation, trends and future outlook for insulin in European markets. The analyses ...

Insulin - United Kingdom by Global Research & Data Services
This market research report offers a perspective on the actual market situation, trends and future outlook for insulin in United Kingdom. The study provides essential ...

See all reports like this >>

More Europe Reports

A Comprehensive Study Of The UK Video Conferencing Equipment Market In 2010, Rating & Valuing Each Of The 30 Companies That Operate In Today's Market by Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...

A Comprehensive Study Of The UK Tableware Market In 2010, Rating & Valuing Each Of The 166 Companies That Operate In Today's Market by Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...

A Comprehensive Study Of The UK Surveyors & Valuers Market In 2010, Rating & Valuing Each Of The 943 Companies That Operate In Today's Market by Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...

A Comprehensive Study Of The UK Subsea Engineering Market In 2010, Rating & Valuing Each Of The 142 Companies That Operate In Today's Market by Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...

A Comprehensive Study Of The UK Structural Engineering Consultancy Market In 2010, Rating & Valuing Each Of The 300 Companies That Operate In Today's Market by Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...

See all reports like this >>

Determining European KOL Compensation Fair-Market Value Benchmarks

Share this report

Other tasks

Research Assistance

Related Markets

Pharmaceuticals Reports

Free Alert Me service